Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer
- PMID: 28801584
- PMCID: PMC5554205
- DOI: 10.1038/s41598-017-08413-z
Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer
Abstract
To compare protein expression levels, gene mutation and survival among Right-Sided Colon Cancer (RSCC), Left-Sided Colon Cancer (LSCC) and rectal cancer patients, 57 cases of RSCC, 87 LSCC and 145 rectal cancer patients were included retrospectively. Our results demonstrated significant differences existed among RSCC, LSCC and rectal cancer regarding tumor diameter, differentiation, invasion depth and TNM stage. No significant difference was identified in expression levels of MLH1, MSH2, MSH6, PMS2, β-Tubulin III, P53, Ki67 and TOPIIα, and gene mutation of KRAS and BRAF among three groups. Progression Free Survival (PFS) of RSCC was significantly lower than that of LRCC and rectal cancer. In univariate analyses, RSCC, preoperative chemoradiotherapy, poor differentiation, advanced TNM stage, elevated serum CEA and CA19-9 level, tumor deposit, perineural and vascular invasion were found to be predictive factors of shorter PFS. In multivariate analyses, only differentiation and TNM stages were found to be independent predictors of PFS. In conclusion, compared with LSCC and rectal cancer, RSCC has larger tumor size, poor differentiation, advanced TNM stage and shorter survival. The shorter survival in RSCC might be attributed to the advanced tumor stage caused by its inherent position feature of proximal colon rather than genetic difference.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5554205/bin/41598_2017_8413_Fig1_HTML.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5554205/bin/41598_2017_8413_Fig2_HTML.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5554205/bin/41598_2017_8413_Fig3_HTML.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5554205/bin/41598_2017_8413_Fig4_HTML.gif)
Similar articles
-
[Expression of TROP2 mRNA in left-sided and right-sided colon cancer and its clinical significance].Zhonghua Wei Chang Wai Ke Za Zhi. 2009 May;12(3):285-9. Zhonghua Wei Chang Wai Ke Za Zhi. 2009. PMID: 19434540 Chinese.
-
Comparison of survival between right-sided and left-sided colon cancer in different situations.Cancer Med. 2018 Apr;7(4):1141-1150. doi: 10.1002/cam4.1401. Epub 2018 Mar 13. Cancer Med. 2018. PMID: 29533001 Free PMC article.
-
Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles.Int J Oncol. 2010 Sep;37(3):707-18. doi: 10.3892/ijo_00000720. Int J Oncol. 2010. PMID: 20664940
-
Rectal and colon cancer: Not just a different anatomic site.Cancer Treat Rev. 2015 Sep;41(8):671-9. doi: 10.1016/j.ctrv.2015.06.007. Epub 2015 Jun 28. Cancer Treat Rev. 2015. PMID: 26145760 Review.
-
Possible better long-term survival in left versus right-sided colon cancer - a systematic review.Dan Med J. 2012 Jun;59(6):A4444. Dan Med J. 2012. PMID: 22677242 Review.
Cited by
-
Colorectal adenocarcinoma in Uganda: are right-sided and left-sided colon cancers two distinct disease entities?World J Surg Oncol. 2023 Jul 22;21(1):215. doi: 10.1186/s12957-023-03094-7. World J Surg Oncol. 2023. PMID: 37480083 Free PMC article.
-
The Prognostic Significance of RIMKLB and Related Immune Infiltrates in Colorectal Cancers.Front Genet. 2022 Apr 4;13:818994. doi: 10.3389/fgene.2022.818994. eCollection 2022. Front Genet. 2022. PMID: 35444692 Free PMC article.
-
Construction of Novel Prognostic Nomogram for Mucinous and Signet Ring Cell Colorectal Cancer Patients with a Survival Longer Than 5 Years.Int J Gen Med. 2022 Mar 5;15:2549-2573. doi: 10.2147/IJGM.S353523. eCollection 2022. Int J Gen Med. 2022. PMID: 35282643 Free PMC article.
-
Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer.Clin Cancer Res. 2022 May 2;28(9):1863-1870. doi: 10.1158/1078-0432.CCR-21-3018. Clin Cancer Res. 2022. PMID: 35254413 Free PMC article.
-
Myosteatosis Differentially Affects the Prognosis of Non-Metastatic Colon and Rectal Cancer Patients: An Exploratory Study.Front Oncol. 2021 Nov 11;11:762444. doi: 10.3389/fonc.2021.762444. eCollection 2021. Front Oncol. 2021. PMID: 34858841 Free PMC article.
References
-
- Goto S, et al. Differences in surgical site infection between laparoscopic colon and rectal surgeries: sub-analysis of a multicenter randomized controlled trial (Japan-Multinational Trial Organization PREV 07-01) Int J Colorectal Dis. 2016;31:1775–1784. doi: 10.1007/s00384-016-2643-1. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous